Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial

  1. Steg, P.G.
  2. Bhatt, D.L.
  3. James, S.K.
  4. Darlington, O.
  5. Hoskin, L.
  6. Simon, T.
  7. Fox, K.M.
  8. Leiter, L.A.
  9. Mehta, S.R.
  10. Harrington, R.A.
  11. Himmelmann, A.
  12. Ridderstråle, W.
  13. Andersson, M.
  14. Bueno, H.
  15. De Luca, L.
  16. Tank, A.
  17. Mellström, C.
  18. McEwan, P.
Revue:
European heart journal. Cardiovascular pharmacotherapy

ISSN: 2055-6845

Année de publication: 2022

Volumen: 8

Número: 8

Pages: 777-785

Type: Article

DOI: 10.1093/EHJCVP/PVAC032 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus